Judge Upholds PharmAthene-SIGA Smallpox Drug Profit Share
A Delaware judge on Thursday upheld his September ruling granting PharmAthene Inc. a share in profits from SIGA Technologies Inc.'s smallpox drug after finding that SIGA breached an agreement to negotiate...To view the full article, register now.
Already a subscriber? Click here to view full article